William J. Wechter

3.0k total citations
83 papers, 2.4k citations indexed

About

William J. Wechter is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, William J. Wechter has authored 83 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 22 papers in Organic Chemistry and 17 papers in Pharmacology. Recurrent topics in William J. Wechter's work include Inflammatory mediators and NSAID effects (17 papers), DNA and Nucleic Acid Chemistry (11 papers) and Estrogen and related hormone effects (10 papers). William J. Wechter is often cited by papers focused on Inflammatory mediators and NSAID effects (17 papers), DNA and Nucleic Acid Chemistry (11 papers) and Estrogen and related hormone effects (10 papers). William J. Wechter collaborates with scholars based in United States, Germany and Singapore. William J. Wechter's co-authors include Darko Kantoci, Euan Murray, David G. Kaiser, Garrett J. Vangiessen, Herbert G. Johnson, P. Goldhaber, M. L. Kaplan, Rhodri Williams, Derin C. D’Amico and M. K. Jeffcoat and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

William J. Wechter

83 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William J. Wechter United States 27 825 574 494 446 294 83 2.4k
C.K. Lim United Kingdom 25 1.4k 1.6× 89 0.2× 176 0.4× 103 0.2× 66 0.2× 115 2.5k
G.M. Anantharamaiah United States 34 1.8k 2.2× 254 0.4× 137 0.3× 245 0.5× 179 0.6× 70 4.9k
Vivek R. Yadav United States 28 1.7k 2.1× 410 0.7× 413 0.8× 250 0.6× 116 0.4× 60 3.5k
Judy Yuet‐Wa Chan Hong Kong 31 1.5k 1.8× 287 0.5× 230 0.5× 94 0.2× 78 0.3× 111 3.1k
Toshikiro Kimura Japan 30 951 1.2× 186 0.3× 354 0.7× 38 0.1× 161 0.5× 111 3.6k
René Santús France 30 878 1.1× 427 0.7× 133 0.3× 506 1.1× 150 0.5× 106 2.4k
Ján Mojžíš Slovakia 32 1.4k 1.7× 762 1.3× 290 0.6× 300 0.7× 122 0.4× 139 3.1k
Takeshi Kumagai Japan 26 1.5k 1.9× 384 0.7× 293 0.6× 286 0.6× 227 0.8× 91 3.1k
Takanori Kumagai Japan 28 1.2k 1.4× 193 0.3× 270 0.5× 135 0.3× 470 1.6× 87 2.6k
Sarvesh Paliwal India 27 718 0.9× 808 1.4× 291 0.6× 77 0.2× 54 0.2× 193 2.9k

Countries citing papers authored by William J. Wechter

Since Specialization
Citations

This map shows the geographic impact of William J. Wechter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William J. Wechter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William J. Wechter more than expected).

Fields of papers citing papers by William J. Wechter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William J. Wechter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William J. Wechter. The network helps show where William J. Wechter may publish in the future.

Co-authorship network of co-authors of William J. Wechter

This figure shows the co-authorship network connecting the top 25 collaborators of William J. Wechter. A scholar is included among the top collaborators of William J. Wechter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William J. Wechter. William J. Wechter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zemskova, Marina, et al.. (2006). Gene expression profiling in R-flurbiprofen-treated prostate cancer: R-Flurbiprofen regulates prostate stem cell antigen through activation of AKT kinase. Biochemical Pharmacology. 72(10). 1257–1267. 10 indexed citations
2.
Grammas, Paula, Shenyun Mou, Quentin N. Pye, et al.. (2004). Anti-inflammatory effects of tocopherol metabolites. Biochemical and Biophysical Research Communications. 319(3). 1047–1052. 80 indexed citations
3.
Hensley, Kenneth, Roberto Bolli, Philip C. Comp, et al.. (2003). New perspectives on vitamin E: γ-tocopherol and carboxyethylhydroxychroman metabolites in biology and medicine. Free Radical Biology and Medicine. 36(1). 1–15. 244 indexed citations
4.
Wechter, William J., et al.. (2000). Treatment and survival study in the C57BL/6J-APCMin/+ (Min) mouse with R-flurbiprofen. Life Sciences. 66(8). 745–753. 55 indexed citations
5.
Wechter, William J. & Euan Murray. (1998). Has the Elusive ‘Natriuretic Factor’ Been Discovered, and If So, Is It a Hormone?. Nephron Experimental Nephrology. 6(6). 488–490. 7 indexed citations
6.
Wechter, William J.. (1996). 1996 symposium on S(+) Ibuprofen : update. 1 indexed citations
7.
Kantoci, Darko, et al.. (1996). Synthesis of Aminobisphosphonate. Synthetic Communications. 26(10). 2037–2043. 40 indexed citations
8.
Kantoci, Darko & William J. Wechter. (1996). Calculation of Inversion Half‐Lives of Aryl Propionic Acid Class Nonsteroidal Antiinflammatory Drugs. The Journal of Clinical Pharmacology. 36(6). 500–504. 7 indexed citations
9.
Wechter, William J., et al.. (1996). Human Plasma Concentrations of R, S, and Racemic Flurbiprofen Given as a Toothpaste. The Journal of Clinical Pharmacology. 36(6). 546–553. 6 indexed citations
10.
Wechter, William J., et al.. (1996). A new endogenous natriuretic factor: LLU-alpha.. Proceedings of the National Academy of Sciences. 93(12). 6002–6007. 156 indexed citations
11.
Wechter, William J., et al.. (1996). Antiproliferative Effects of the Enantiomers of Flurbiprofen. The Journal of Clinical Pharmacology. 36(6). 540–545. 50 indexed citations
12.
Burris, James F. & William J. Wechter. (1994). A Report on the ACCP Membership Survey. The Journal of Clinical Pharmacology. 34(2). 95–98. 1 indexed citations
13.
Wechter, William J.. (1994). Drug Chirality: On the Mechanism of R‐Aryl Propionic Acid Class NSAIDs. Epimerization in Humans and the Clinical Implications for the Use of Racemates. The Journal of Clinical Pharmacology. 34(11). 1036–1042. 54 indexed citations
14.
Wechter, William J., et al.. (1994). Chiral pharmacokinetics of rac‐flurbiprofen and pharmacodynamics of anabolic bone response in the normal rat. Chirality. 6(6). 457–459. 7 indexed citations
15.
Zeng, Qinghe, W.S.S. Jee, Hua Zhu Ke, & William J. Wechter. (1993). S-Ketoprofen inhibits tenotomy-induced bone loss and dynamics in weanling rats. Bone and Mineral. 21(3). 203–218. 9 indexed citations
16.
Murray, Euan, et al.. (1993). Endogenous natriuretic factors 1: Sodium pump inhibition does not correlate with natriuretic or pressor activities from uremic urine. Life Sciences. 52(12). 1045–1054. 8 indexed citations
17.
Lichtstein, David, S. Samuelov, Irith Gati, & William J. Wechter. (1992). Digitalis-Like Compounds in Animal Tissues. Journal of Basic and Clinical Physiology and Pharmacology. 3(4). 269–292. 20 indexed citations
18.
Wechter, William J.. (1992). The effects of NSAIDs and E-prostaglandins on bone: A two signal hypothesis for the maintenance of skeletal bone. Birkhäuser Basel eBooks. 39. 351–364. 10 indexed citations
19.
Wechter, William J., et al.. (1990). Natriuretic hormones. Birkhäuser Basel eBooks. 34. 231–260. 4 indexed citations
20.
Wechter, William J., et al.. (1975). ChemInform Abstract: ARA‐CYTIDINE ACYLATES, USE OF DRUG DESIGN PREDICTORS IN STRUCTURE‐ACTIVITY RELATIONSHIP CORRELATION. Chemischer Informationsdienst. 6(29). 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C.K. Lim Breakdown of academic impact, for papers by G.M. Anantharamaiah Breakdown of academic impact, for papers by Vivek R. Yadav Breakdown of academic impact, for papers by Judy Yuet‐Wa Chan Breakdown of academic impact, for papers by Toshikiro Kimura Breakdown of academic impact, for papers by René Santús Breakdown of academic impact, for papers by Ján Mojžíš Breakdown of academic impact, for papers by Takeshi Kumagai Breakdown of academic impact, for papers by Takanori Kumagai Breakdown of academic impact, for papers by Sarvesh Paliwal
Rankless by CCL
2026